The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers

被引:10
|
作者
Benko, Tamas [1 ]
Gallinat, Anja [1 ]
Minor, Thomas [1 ]
Saner, Fuat H. [1 ]
Sotiropoulos, Georgios C. [1 ]
Paul, Andreas [1 ]
Hoyer, Dieter P. [1 ]
机构
[1] Univ Essen Duisburg, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany
关键词
extended criteria donor; liver graft dysfunction; postoperative Model for End stage Liver Disease; risk assessment; EARLY ALLOGRAFT DYSFUNCTION; SINGLE-CENTER EXPERIENCE; PRIMARY NONFUNCTION; GRAFT FUNCTION; MELD; RETRANSPLANTATION; PRESERVATION; DEFINITION; ALLOCATION; RECIPIENTS;
D O I
10.1097/MEG.0000000000000851
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Recently, the postoperative Model for End stage Liver Disease score (POPMELD) was suggested as a definition of postoperative graft dysfunction and a predictor of outcome after liver transplantation (LT). Aim The aim of the present study was to validate this concept in the context of extended criteria donor (ECD) organs. Patients and methods Single-center prospectively collected data (OPAL study/01/11-12/13) of 116 ECD LTs were utilized. For each recipient, the Model for End stage Liver Disease (MELD) score was calculated for 7 postoperative days (PODs). The ability of international normalized ratio, bilirubin, aspartate aminotransferase, Donor Risk Index, a recent definition of early allograft dysfunction, and the POPMELD was compared to predict 90-day graft loss. Predictive abilities were compared by receiver operating characteristic curves, sensitivity and specificity, and positive and negative predictive values. Results The median Donor Risk Index was 1.8. In all, 60.3% of recipients were men [ median age of 54 (23-68) years]. The median POD1-7 peak-aspartate aminotransferase value was 1052 (194-17 577) U/l. The rate of early allograft dysfunction was 22.4%. The 90-day graft survival was 89.7%. Out of possible predictors of the 90-day graft loss MELD on POD5 was the best predictor of outcome (area under the curve = 0.84). A MELD score of 16 or more on POD5 predicted the 90-day graft loss with a specificity of 80.8%, a sensitivity of 81.8%, and a positive and negative predictive value of 31 and 97.7%. Conclusion A MELD score of 16 or more on POD5 is an excellent predictor of outcome in ECD donor LT. Routine evaluation of POPMELD scores might support clinical decision-making and should be reported routinely in clinical trials. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 50 条
  • [21] Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35
    Yun, Sang Oh.
    Kim, Jongman
    Rhu, Jinsoo
    Choi, Gyu-Seong
    Joh, Jae-Won
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (12) : 1293 - 1303
  • [22] Factors that affect deceased donor liver transplantation rates in the United States in addition to the model for end-stage liver disease score
    Sharma, Pratima
    Schaubel, Douglas E.
    Messersmith, Emily E.
    Guidinger, Mary K.
    Merion, Robert M.
    LIVER TRANSPLANTATION, 2012, 18 (12) : 1456 - 1463
  • [23] Impact of donor age on short-term outcomes after pediatric split liver transplantation
    Xu, Min
    Dong, Chong
    Sun, Chao
    Wang, Kai
    Zhang, Wei
    Qin, Hong
    Han, Chao
    Yang, Yang
    Zhang, Fubo
    Wang, Zhen
    Zheng, Weiping
    Wei, Xinzhe
    Gao, Wei
    Shen, Zhongyang
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [24] Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience
    Rosenthal, Benjamin E.
    Abt, Peter L.
    Schaubel, Douglas E.
    Reddy, K. Rajender
    Bittermann, Therese
    TRANSPLANTATION, 2024, 108 (03) : 713 - 723
  • [25] Application of Postoperative Model for End-Stage Liver Disease Scoring System for Evaluating Liver Graft Function After Living Donor Liver Transplantation
    Toshima, T.
    Ikegami, T.
    Kimura, K.
    Harimoto, N.
    Yamashita, Y.
    Yoshizumi, T.
    Soejima, Y.
    Ikeda, T.
    Shirabe, K.
    Maehara, Y.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (01) : 81 - 86
  • [26] National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35
    Nekrasov, V.
    Matsuoka, L.
    Rauf, M.
    Kaur, N.
    Cao, S.
    Groshen, S.
    Alexopoulos, S. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (10) : 2912 - 2924
  • [27] Pretransplant Model for End-stage Liver Disease Score Has No Impact on Posttransplant Survival in Living Donor Liver Transplantation
    Wai, C-T.
    Woon, W-A.
    Tan, Y-M.
    Lee, K-H.
    Tan, K-C.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (02) : 396 - 398
  • [28] Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation
    Lichtenstern, Christoph
    Hochreiter, Marcel
    Zehnter, Verena D.
    Brenner, Thorsten
    Hofer, Stefan
    Mieth, Markus
    Buechler, Markus W.
    Martin, Eike
    Weigand, Markus A.
    Schemmer, Peter
    Busch, Cornelius J.
    MYCOSES, 2013, 56 (03) : 350 - 357
  • [29] Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation
    Alonso, I. J.
    Maestro, O. C.
    Gomez, N. F.
    Mateos, R. S.
    Quinto, A. M.
    Molero, F. C.
    Municio, A. M.
    Pulido, J. C.
    Segurola, C. L.
    Romero, C. J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 97 - 99
  • [30] The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation
    Tang Yunhua
    Ju Weiqiang
    Chen Maogen
    Yang Sai
    Zhang Zhiheng
    Wang Dongping
    Guo Zhiyong
    He Xiaoshun
    Journal of Clinical Monitoring and Computing, 2018, 32 : 471 - 479